Xponance Inc. Sells 13,270 Shares of Centene Co. (NYSE:CNC)

Xponance Inc. lowered its position in shares of Centene Co. (NYSE:CNC) by 13.9% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 82,231 shares of the company’s stock after selling 13,270 shares during the quarter. Xponance Inc.’s holdings in Centene were worth $4,982,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently made changes to their positions in the company. Capital Advisors Ltd. LLC grew its stake in shares of Centene by 75.3% during the fourth quarter. Capital Advisors Ltd. LLC now owns 412 shares of the company’s stock worth $25,000 after purchasing an additional 177 shares during the period. Rialto Wealth Management LLC acquired a new stake in shares of Centene during the fourth quarter worth $30,000. OFI Invest Asset Management acquired a new stake in shares of Centene during the fourth quarter worth $33,000. SRS Capital Advisors Inc. grew its stake in shares of Centene by 73.4% during the fourth quarter. SRS Capital Advisors Inc. now owns 631 shares of the company’s stock worth $38,000 after purchasing an additional 267 shares during the period. Finally, Riverview Trust Co grew its stake in shares of Centene by 172.7% during the fourth quarter. Riverview Trust Co now owns 758 shares of the company’s stock worth $46,000 after purchasing an additional 480 shares during the period. Institutional investors own 93.63% of the company’s stock.

Analyst Ratings Changes

A number of equities research analysts recently commented on CNC shares. Argus cut Centene from a “buy” rating to a “hold” rating in a research note on Thursday, February 6th. Stephens decreased their price objective on Centene from $75.00 to $73.00 and set an “equal weight” rating for the company in a research note on Friday, December 13th. Cantor Fitzgerald reissued an “overweight” rating and issued a $90.00 target price on shares of Centene in a research note on Wednesday, December 11th. Robert W. Baird boosted their target price on Centene from $66.00 to $71.00 in a research note on Tuesday, February 4th. Finally, Barclays boosted their target price on Centene from $91.00 to $93.00 and gave the company an “overweight” rating in a research note on Friday, December 13th. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and ten have given a buy rating to the company. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $79.92.

Centene Stock Down 0.7 %

CNC stock opened at $59.26 on Thursday. The company has a debt-to-equity ratio of 0.70, a current ratio of 1.11 and a quick ratio of 1.10. The stock has a market capitalization of $29.40 billion, a P/E ratio of 9.50, a P/E/G ratio of 0.80 and a beta of 0.40. The business has a 50-day moving average of $60.39 and a 200-day moving average of $63.43. Centene Co. has a fifty-two week low of $55.03 and a fifty-two week high of $80.59.

Centene (NYSE:CNC) last released its earnings results on Tuesday, February 4th. The company reported $0.80 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.49 by $0.31. Centene had a return on equity of 13.85% and a net margin of 2.03%. The business had revenue of $40.81 billion for the quarter, compared to analyst estimates of $38.78 billion. During the same quarter in the prior year, the company posted $0.45 earnings per share. Centene’s revenue was up 3.4% on a year-over-year basis. On average, sell-side analysts anticipate that Centene Co. will post 6.86 earnings per share for the current fiscal year.

Centene Profile

Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children’s health insurance program, foster care, medicare-medicaid plans, long-term services and support.